# AlloSource – FDA Inspection, Aug 4, 2025

Source: https://www.keypedia.com/records/fda_inspections/allosource/ca5f26f3-640f-4459-80ae-a2e03dafef5a
Source feed: FDA_Inspections

> FDA inspection 1278944 of AlloSource, August 04, 2025. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1278944
- Company Name: AlloSource
- Inspection Date: 2025-08-04
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1083311 - 2019-02-26
- [FDA Inspection 544221 - 2008-10-03](https://www.keypedia.com/records/fda_inspections/allosource/1ccd910f-695b-421b-a0f6-a9be6635faca)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/gabryelle-j-solverud/29c4452f-2f7a-4325-8f8d-7046fcb4690f)

Company: https://www.keypedia.com/companies/allosource/014c5d12-8d08-44d1-88ae-a7b76e12c2a0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d